首页> 外文期刊>臨床病理 >血管新生とHGF:糖尿病性網膜症における血管新生と眼内HGFについて
【24h】

血管新生とHGF:糖尿病性網膜症における血管新生と眼内HGFについて

机译:血管生成和HGF:糖尿病性视网膜病变中的血管生成和眼内HGF

获取原文
获取原文并翻译 | 示例
           

摘要

Human hepatocyte growth factor (hHGF) has a strong angioneogenetic action. The present study was designed to investigate the possible involvement of hHGF in neovascularization in proliferative diabetic retinopathy by measuring vitreous hHGF concentration, and to examine the gene expression of hHGF in retinal Miiller cells, which are presumed to play a role in proliferative diabetic retinopathy. Patients who had undergone pars plana vitrectomy were studied (33 diabetic patients with proliferative retinopathy and 20 nondiabetic subjects). The mean vitreous hHGF concentration was higher (p< 0.0001) in diabetic subjects with proliferative retinopathy (5.7+-0.7ng/ml) than in nondiabetic subjects (1.6+-0.2ng/ml). Furthermore, diabetic subjects with iris neovascularization, which is suggestive of advanced retinal ischemia, showed higher values of mean vitreous hHGF concentration than those without iris neovascularization (7.3 +-1.2ng/ml[n=14] vs. 4.5+-0.7ng/ml[n=19], p<0.01). Expression of hHGF gene was detected in cultured human Miiller cells. Our results indicate that hHGF may be produced in the eye by retinal cells such as Miiller cells and may play a role in neovascularization of proliferative diabetic retinopathy.
机译:人肝细胞生长因子(hHGF)具有很强的血管生成作用。本研究旨在通过测量玻璃体hHGF的浓度来研究hHGF在增生性糖尿病视网膜病变的新生血管形成中的可能参与,并研究hHGF在视网膜Miiller细胞中的基因表达,假定其在增生性糖尿病视网膜病变中起作用。研究了进行了平面pars玻璃体切除术的患者(33例患有增生性视网膜病变的糖尿病患者和20例非糖尿病患者)。患有增生性视网膜病变的糖尿病患者的玻璃体hHGF的平均浓度(5.7 + -0.7ng / ml)高于非糖尿病患者(1.6 + -0.2ng / ml)。此外,有虹膜新生血管形成的糖尿病患者提示视网膜局部缺血,与没有虹膜新生血管形成的患者相比,玻璃体hHGF的平均浓度值更高(7.3 + -1.2ng / ml [n = 14]与4.5 + -0.7ng / ml ml [n = 19],p <0.01)。在培养的人Miiller细胞中检测到hHGF基因的表达。我们的结果表明,hHGF可能是由视网膜细胞(如Miiller细胞)在眼中产生的,并且可能在增生性糖尿病视网膜病变的新血管形成中起作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号